Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.
about
Role of immunotherapy in the treatment of allergic asthmaSublingual immunotherapy in children with allergic rhinitis: quality of systematic reviews.Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.The discovery of potent, selective, and reversible inhibitors of the house dust mite peptidase allergen Der p 1: an innovative approach to the treatment of allergic asthmaThe need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practicePeptide immunotherapy for allergic disease.Actual therapeutic management of allergic and hyperreactive nasal disordersEarly detection of allergic diseases in otorhinolaryngologyGuideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoSublingual immunotherapy for allergic rhinoconjunctivitis--the seeming and the real.Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review.Food-specific sublingual immunotherapy is well tolerated and safe in healthy dogs: a blind, randomized, placebo-controlled studyAllergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analysesFurther marches: allergic and non-allergic.Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction.House dust allergy and immunotherapy.A new mechanism for inhalational priming: IL-4 bypasses innate immune signals.Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days.Undertreatment of allergy: exploring the utility of sublingual immunotherapy.Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus reportClinical practice: Allergen-specific immunotherapy in children: facts and FAQs.Safety evaluation of rapid build-up schedules with IR-standardized allergen extracts for subcutaneous immunotherapy of allergic respiratory diseases.One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions.Therapeutic effects and biomarkers in sublingual immunotherapy: a review.Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations.Pharmacotherapy of allergic rhinitis: current options and future perspectives.Preventive capacity of allergen immunotherapy on the natural history of allergyPreventing progression of allergic rhinitis to asthma.Emerging drugs for allergic conjunctivitis.Allergen immunotherapy for the prevention of allergic disease: protocol for a systematic review.Immunotherapy in allergic rhinitis and lower airway outcomes.Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis.Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient.Multiallergen-specific immunotherapy in polysensitized patients: where are we?Specific allergen immunotherapy: effect on IgE, IgG4 and chemokines in patients with allergic rhinitis.Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy.Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis.Upregulated levels of human β-defensins in patients with seasonal allergic rhinitis after allergen-specific immunotherapy treatment.Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate.Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more.
P2860
Q27021489-AB785C1F-401F-47C2-8E4E-DED51B8D544FQ31030974-B1C5FA31-6691-4818-88EF-F032B6DEFD55Q33378244-BE261F89-721F-4987-B476-49EF5BAD1425Q34446046-09A92702-2A28-4306-BC47-F27DB2D4191DQ35052674-49E40147-A05B-4F3A-AEE5-25249F3F8A79Q35164800-C0864DFC-9091-4D71-B605-716D48A5A020Q35427205-0C0E4EC4-57ED-4EB3-B7A4-C7ED967A28DFQ35427549-111D1099-37B9-43F8-85F2-67BC14094F38Q35777126-5FEC01D3-F4DE-46C8-A324-873399C616AAQ36157889-E7D1D942-686D-4610-B2BA-5BCBA43093D8Q36215069-9A71784C-0257-4B4C-8B14-F9E585E554FBQ36253230-C225CC66-0CD4-4409-A27B-E679C220B2BDQ36411170-655381C0-D936-46D0-B9E8-63F3C6B9689CQ36789966-42A6B5C7-7685-4FA4-A776-394F8B71E436Q36826600-91C5F530-78C5-4067-817A-A6EF73FF0C0FQ36863569-3BE615C4-CAA7-4889-AB3D-BFC4CAAC76CAQ37215891-D6E7D22C-2989-4CAF-9679-EF6313C455D7Q37355463-5E000B37-421F-46B5-A183-14D3CF0F2EB9Q37459337-FFB0E672-B312-49BF-8F13-D0D09EBD405BQ37696401-894288B9-C552-473F-AC56-9B24F9DEE07BQ37820336-A42BB52A-407E-46D1-954D-08B8414212B9Q37902666-D1637DC5-23A9-434D-9ED5-4C9B047CC14CQ37981739-DDE5A206-7F9A-4905-941D-252180F69BA4Q38002411-0DB77E1E-80C1-4BDC-B7DE-5DEA8D19139AQ38025664-DC3C24D1-1AF3-4DAB-9D24-3C3802F4A3B1Q38161991-A9DDF70D-BD05-44FE-9A79-8EB6DA0112CEQ38176377-3ADFDDAB-360F-4817-AAA7-ABF7CD523482Q38177218-28400F12-6199-48D6-BEEA-488991FD014EQ38198760-27AA16CE-1691-4CF6-A4D0-9ACC5EF66EAAQ38667404-77602194-8276-4D81-B3BA-7776F8DED1EAQ38903486-8BA3D417-4263-48A2-99E6-C8C0604FBFECQ38960803-3B8CB53F-BFF8-4D52-A36C-65AC2808A1C0Q38968310-0BBEA211-06CE-41AA-B6C7-95C5277ABD2CQ39466603-41D60116-6065-4FE5-8980-E9A048B3732FQ40790855-6B0C689C-491B-48AC-8B2B-D06826759786Q42153928-0F279DB8-6A5C-4E3D-A9C5-5512AEEE3A1FQ42428008-4C0B3BD1-5353-42E5-913A-F51869D048FBQ44201691-BE0391AD-BA16-4310-8BC3-CCD323E886D9Q44680424-C3C8E160-D3F5-45B7-9593-B804BAAAC568Q45088211-AD4F9F12-8CE8-4283-A2BC-85348FCD7C2F
P2860
Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Prevention of new sensitizatio ...... or not. A retrospective study.
@en
Prevention of new sensitizatio ...... or not. A retrospective study.
@nl
type
label
Prevention of new sensitizatio ...... or not. A retrospective study.
@en
Prevention of new sensitizatio ...... or not. A retrospective study.
@nl
prefLabel
Prevention of new sensitizatio ...... or not. A retrospective study.
@en
Prevention of new sensitizatio ...... or not. A retrospective study.
@nl
P2093
P2860
P1476
Prevention of new sensitizatio ...... or not. A retrospective study
@en
P2093
F Purello-D'Ambrosio
P Puccinelli
R A Merendino
S Parmiani
P2860
P304
P356
10.1046/J.1365-2222.2001.01027.X
P577
2001-08-01T00:00:00Z